Caricamento...
Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review)
The immune checkpoint blockade is an effective strategy to enhance the anti-tumor T cell effector activity, thus becoming one of the most promising immunotherapeutic strategies in the history of cancer treatment. Several immune checkpoint inhibitor have been approved by the FDA, such as anti-CTLA-4,...
Salvato in:
| Pubblicato in: | Int J Mol Med |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
D.A. Spandidos
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7797440/ https://ncbi.nlm.nih.gov/pubmed/33416134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2020.4817 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|